Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase omega-1 (GSTO1-1) is a cytosolic enzyme belonging to the omega class of glutathione transferases, characterized by a unique active site cysteine and specialized redox functions. It exhibits glutathione-dependent thiol transferase and dehydroascorbate reductase activities, contributing to cellular redox homeostasis and the glutathione-ascorbate antioxidant cycle[6][2]. GSTO1-1 catalyzes protein (de)glutathionylation, playing a regulatory role in protein function and inflammatory signaling, especially via modulation of TLR4 pathways[1]. GSTO1-1 is implicated in cancer cell proliferation and migration, and its genetic or pharmacological inhibition can attenuate inflammatory responses, making it a potential therapeutic target in inflammatory diseases, cancer, and oxidative stress-related disorders[5][1][4].
Covalent and non-covalent inhibition of GSTO1-1 enzymatic activity, Blockade of protein glutathionylation and LPS-stimulated pro-inflammatory signaling[1][4]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase omega-1 (GSTO1).